Rights and permissions
About this article
Cite this article
Bortezomib approved in Canada for multiple myeloma. Inpharma Wkly. 1474, 18 (2005). https://doi.org/10.2165/00128413-200514740-00048
Published:
Issue Date:
DOI: https://doi.org/10.2165/00128413-200514740-00048